These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 25112864)

  • 1. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice.
    Cooper JM; Wiklander PB; Nordin JZ; Al-Shawi R; Wood MJ; Vithlani M; Schapira AH; Simons JP; El-Andaloussi S; Alvarez-Erviti L
    Mov Disord; 2014 Oct; 29(12):1476-85. PubMed ID: 25112864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
    Spencer B; Trinh I; Rockenstein E; Mante M; Florio J; Adame A; El-Agnaf OMA; Kim C; Masliah E; Rissman RA
    Neurobiol Dis; 2019 Jul; 127():163-177. PubMed ID: 30849508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology.
    Izco M; Blesa J; Schleef M; Schmeer M; Porcari R; Al-Shawi R; Ellmerich S; de Toro M; Gardiner C; Seow Y; Reinares-Sebastian A; Forcen R; Simons JP; Bellotti V; Cooper JM; Alvarez-Erviti L
    Mol Ther; 2019 Dec; 27(12):2111-2122. PubMed ID: 31501034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
    Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.
    Gerard M; Deleersnijder A; Daniëls V; Schreurs S; Munck S; Reumers V; Pottel H; Engelborghs Y; Van den Haute C; Taymans JM; Debyser Z; Baekelandt V
    J Neurosci; 2010 Feb; 30(7):2454-63. PubMed ID: 20164329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse.
    Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY
    Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model.
    Ren X; Zhao Y; Xue F; Zheng Y; Huang H; Wang W; Chang Y; Yang H; Zhang J
    Mol Ther Nucleic Acids; 2019 Sep; 17():726-740. PubMed ID: 31437653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
    Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
    Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein.
    Bernis ME; Babila JT; Breid S; Wüsten KA; Wüllner U; Tamgüney G
    Acta Neuropathol Commun; 2015 Nov; 3():75. PubMed ID: 26612754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvascular delivery of small interfering RNA to the central nervous system.
    Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
    Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
    Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
    Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of α-Synuclein in Exosomes.
    Tsunemi T; Ishiguro Y; Yoroisaka A; Hattori N
    Methods Mol Biol; 2021; 2322():41-45. PubMed ID: 34043190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.